loading...| Preferred Name | olanzapine | |
| Synonyms |
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine |
|
| Definitions |
This is any condition in which the main influencing factor is olanzapine, a benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0001019 |
|
| created_by |
slaulede |
|
| creation_date |
2023-05-02T13:01:59Z |
|
| database_cross_reference |
CHEBI:7735 MESH:D000077152 |
|
| definition |
This is any condition in which the main influencing factor is olanzapine, a benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy. |
|
| has_exact_synonym |
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| id |
XCO:0001019 |
|
| label |
olanzapine |
|
| notation |
XCO:0001019 |
|
| prefLabel |
olanzapine |
|
| treeView | ||
| subClassOf |